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ABSTRACT
Background: The benefits of using thrombus aspiration catheters 
during primary percutaneous coronary intervention (PCI) to 
obtain better coronary flow and myocardial perfusion and to 
reduce late mortality are established in the literature. However, 
in clinical practice, this approach does not appear to be used 
for all patients. This study attempted to determine which clinical 
and angiographic variables have led to the use of these devices 
in primary PCI at this institution. Methods: From August of 2006 
to November of 2010, 558 consecutive patients underwent 
primary PCI. Thrombus aspiration catheters were used in 79 
patients (group 1), who were then compared to 479 patients 
in whom these devices were not used (group 2). Results: 
Group 1 showed a prevalence of males, smokers, large acute 
myocardial infarctions (AMI), and thrombotic lesions. The use 
of glycoprotein IIb/IIIa inhibitors, direct stenting, larger diameter 
stents, and the presence of transient coronary flow disturbances 
were also more frequent in group 1. The procedural success 
rate was high (93.7% vs. 92.3%; P = 0.4), and it was similar 
between groups. At hospital discharge, the incidence of major 
adverse cardiac and cerebrovascular events (6.3% vs. 6.5%; 
P  =  0.6), death (5.1% vs. 3.8%; P  =  0.58), stroke (1.3% vs. 
0.4%; P = 0.09), and reinfarction (0% vs. 2.3%; P = 0.17) were 
not different between the groups. Conclusions: Thrombus 
aspiration catheters have been used in 15% of primary 
PCIs, usually in AMIs with greater extension and thrombotic 
burden. Despite the more severe clinical and angiographic 
profile of these patients, the success rate is high and similar 
to that of low-risk patients. 
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RESUMO
Perfil de Pacientes Tratados com Cateteres de  
Aspiração de Trombos Durante Intervenção  
Coronária Percutânea Primária
Introdução: Os benefícios da utilização de cateteres de aspi-
ração de trombos durante intervenção coronária percutânea 
(ICP) primária, com obtenção de melhor fluxo coronário e 
perfusão miocárdica e redução da mortalidade tardia, já estão 
estabele cidos na literatura. No entanto, seu uso na prática clínica 
pa rece não estar aplicado a todos os pacientes. Procuramos saber 
quais variáveis clínicas e angiográficas têm norteado a indicação 
desses dispositivos na ICP primária em nosso meio. Métodos: 
No período de agosto de 2006 a novembro de 2010, 558 pa-
cientes foram submetidos consecutivamente a ICP primária. Em 
79 pacientes foram utilizados cateteres de aspiração de trombos 
(grupo 1), comparativamente a 479 pacientes nos quais esses 
dispositivos não foram aplicados (grupo 2). Resultados: O grupo 
1 apresentou predomínio de sexo masculino, tabagistas, infarto 
agudo do miocárdio (IAM) de maior extensão e lesões trombóticas. 
O uso de inibidores da glicoproteína IIb/IIIa, da técnica de stent 
direto e de stents de maior diâmetro e a ocorrência de distúrbios de 
fluxo coro ná rio transitórios também foram mais frequentes no grupo 
1. A taxa de sucesso do procedimento foi alta (93,7% vs. 92,3%; 
P = 0,4) e similar entre os grupos. Na alta hospitalar, a inci dência 
de even tos cardíacos e cerebrovasculares adver sos maiores (6,3% 
vs. 6,5%; P = 0,6), óbito (5,1% vs. 3,8%; P = 0,58), acidente 
vascular cerebral (1,3% vs. 0,4%; P = 0,09) e reinfarto (0% vs. 
2,3%; P = 0,17) não mostrou diferenças entre os grupos. Con-
clusões: Cateteres de aspiração de trombos têm sido utilizados 
em 15% das ICPs primárias, geralmente nos IAM de maior ex-
tensão e com maior carga trombótica. Apesar da maior gravidade 
clínico-angiográfica desses pacientes, o sucesso do procedimento 
é alto e semelhante ao dos demais pacientes de menor risco.
DESCRITORES: Trombectomia. Infarto do miocárdio. Angioplas tia. 
Stents.
© 2012 Elsevier Editora Ltda. and Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista. All rights reserved.
Almeida et al. 
Thrombus Aspiration Catheters during Primary PCI
Rev Bras Cardiol Invasiva. 
2012;20(1):46-52
47
P ercutaneous coronary intervention (PCI) is the treatment of choice for acute ST-segment elevation myocardial infarctions (AMI) when it is performed 
early. The procedure can re-establish normal epicardial 
coronary flow in over 90% of patients, thereby reduc-
ing mortality and the rates of recurrent ischemia and 
reinfarction, with minimal risk of severe haemorrhagic 
complications.1–3 
The interventionist approach to the atherothrombotic 
plaque using guidewires, balloon catheters, and stents 
during primary PCI may lead to thrombus displacement 
or to fragmentation, with consequent embolisation to 
distal coronary branches.4 This result has been verified 
in 15.2% of procedures, and is related to decreased 
coronary flow, the occurrence of no/slow-reflow phe-
nomenon, lower rate of ST-segment normalisation, a 
greater enzyme elevation, worse ventricular function, 
and greater long-term mortality.5–7
The intracoronary aspiration devices introduced in 
the last decade are mechanical or manual thrombus-
aspiration catheters, and are used during primary PCI. 
The first model uses a low-rotation mechanical engine, 
and the second uses aspiration through a syringe. These 
models have been used to perform thrombectomy and 
result in immediate flow improvement as well as better 
myocardial perfusion after the procedure.7,8 A reduc-
tion in death and reinfarction has been reported due 
to the use of manual aspiration devices in randomised 
controlled studies with follow-up of eight to 24 months 
after AMI.9–11 With the mechanical catheters, this benefit 
was also demonstrated 30 days after AMI in a recently 
published major study.12
Despite the well-established benefits in the litera-
ture and a classification of recommendation IIa, level 
of evidence B, in the current guidelines, the use of 
these devices is still not universally applied to patients 
undergoing primary PCI.1,13,14 This article aimed to 
characterise the profile of the patients treated in the 
present institution with such devices during primary PCI.
METHODS
Patients
From August of 2006 to November of 2010, 558 
primary coronary interventions were performed con-
secutively at the Haemodynamics and Interventional 
Cardiology Service of the Hospital Bandeirantes (São 
Paulo, SP, Brazil). In 79 of these procedures, thrombus 
aspiration catheters were used (group 1). These proce-
dures were compared with those (479) in which the 
catheters were not used (group 2).
Data were prospectively collected and stored in a 
computerised database.
The clinical and angiographic profiles were ana-
lysed, as well as those related to the procedure, in 
addition to the success rate and clinical progression 
until discharge from the hospital.
Percutaneous coronary intervention
Almost all interventions were performed through 
femoral access. In a few cases, radial or brachial ac-
cess was chosen. The surgeons were responsible for 
selecting the technique and the materials to be used 
during the procedure. They were also responsible for 
identifying the necessity of aspiration catheters and 
glycoprotein IIb/IIIa inhibitors. For thrombectomy or 
thrombus aspiration, all devices used were manual 
aspiration catheters Pronto® and Pronto® V3 (Vascular 
Solutions – Minneapolis, USA), DiverTM (Invatec – Brescia, 
Italy), or Export® (Medtronic - Minneapolis, USA). At 
the beginning of the procedure, a 70 U/kg to 100 U/
kg dose of unfractionated heparin (50  U/kg to 70  U/
kg in the case of concomitant use of glycoprotein IIb/
IIIa inhibitors) was administered. The no/slow-reflow 
phenomenon was pharmacologically treated with in-
tracoronary admi nistration of adenosine and/or isosor-
bide mononitrate associated with glycoprotein IIb/IIIa 
inhibitors. All patients received dual antiplatelet therapy 
with acetylsalicylic acid (loading dose: 200  mg and 
100 mg/day for maintenance) and clopidogrel (loading 
dose: 300–600 mg and 75 mg/day for maintenance) or 
ticlopidine (250 mg every 12 hours). Femoral sheaths 
were removed four hours after heparin administration. 
Radial sheaths were removed immediately after the end 
of the procedure.
Angiographic analysis and definitions
The analysis were performed by expert surgeons in at 
least two orthogonal projections using digital quantitative 
coronary angiography. The angiographic criteria from the 
Brazilian National Centre for Cardiovascular Interventions 
(CENIC) of the Brazilian Society of Haemodynamics 
and Interventional Cardiology (SBHCI) were used in 
the present study. The criteria of the American College 
of Cardiology and the American Heart Association for 
type of lesion were used.15 Lesions >  20  mm were 
considered long. For the evaluation of coronary flow 
before and after the procedure, the Thrombolysis in 
Myocardial Infarction (TIMI) classification was used.16 
The success of the procedure was defined as angio-
graphic success (residual stenosis <  30% with TIMI 
3 flow) and absence of major adverse cardiac and 
cerebrovascular events (MACCE), including death, 
reinfarction, stroke, and emergency coronary artery 
bypass graft surgery.1 Reinfarction was defined as 
the presence of electrocardiographic alterations (new 
ST-segment elevation or new Q waves) and/or angio-
graphic evidence of targeted vessel occlusion. Surgery 
performed immediately after percutaneous coronary 
intervention was considered an emergency coronary 
artery bypass graft (CABG) surgery. The analysis also 
considered all-cause mortality and cardiac mortality 
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(cardiogenic shock, heart failure, AMI, cardiac rupture, 
arrhythmia, and sudden death) during hospital stay.
Statistical analysis
Data stored in Oracle databases were plotted in 
Excel worksheets in the Statistical Package for Social 
Sciences (SPSS), release 15.0. Continuous variables were 
expressed as mean ± standard deviation and categorical 
variables were expressed as percentiles. The associa-
tions among the continuous variables were evaluated 
with Student’s t-test and analysis of variance (ANOVA). 
The associations among the cate gorical variables were 
evaluated by the chi-squared test or by Fischer’s exact 
test in 2 x 2 contingency tables. In greater contingency 
tables, the chi-squared test or the G tests were applied. 
The significance level was set at P  <  0.05.
RESULTS
Table 1 presents the clinical characteristics of 
both groups.
In 14.1% of primary PCI procedures, an aspira-
tion catheter was used; these patients comprised group 
1. This group had a greater number of male patients 
(84.8% vs. 71.2%; P  =  0.01) and smokers (39.2% vs. 
25.3%; P = 0.01), when compared with group 2. There 
were no diffe rences between the groups regarding age, 
presence of arterial hypertension, diabetes mellitus, 
dyspilidaemia, prior myocardial infarction, prior PCI, 
prior CABG surgery, infarction location detected by 
electrocardiography, or functional Killip class.
Tables 2 and 3 present the angiographic and pro-
cedural characteristics.
TABLE 1 
Clinical Characteristics
Characteristics 
Group 1  
(n = 79)
Group 2  
(n = 479) P
Male gender, n (%) 67 (84.8) 341 (71.2) 0.01
Age, years 59 ± 12.3 61.6 ± 12.8 0.1
Arterial hypertension, n (%) 46 (58.2) 325 (67.8) 0.09
Dyspilidaemia, n (%) 25 (31.6) 115 (24) 0.15
Diabetes mellitus, n (%) 15 (19) 121 (25.3) 0.23
Tobacco smoking, n (%) 31 (39.2) 121 (25.3) 0.01
Prior AMI, n (%) 9 (11.4) 43 (9) 0.49
Prior PCI, n (%) 5 (6.3) 47 (9.8) 0.32
Previous CABG, n (%)   5 (6.3) 25 (5.2) 0.69
Killip, n (%)
I
II
III
IV
60 (76)
11 (13.9)
3 (3.8)
5 (6.3)
367 (76.6)
67 (14)
12 (2.5)
33 (6.9)
0.9
AMI site, n (%)
Inferior/dorsal
Inferior
Anterior
Inferolateral dorsal
Anterolateral
Lateral
Dorsal
3 (3.8)
28 (35.9)
22 (28.2)
13 (16.7)
10 (12.8)
1 (1.3)
1 (1.3)
35 (7.6)
163 (35.4)
179 (38.8)
37 (8)
29 (6.3)
13 (2.8)
5 (1.1)
0.06
AMI = acute myocardial infarction; PCI = percutaneous coronary intervention; n = number of patients; CABG = coronary artery bypass 
graft surgery. 
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TABLE 2 
Angiographic Characteristics
Characteristics 
Group 1  
(79 patients/ 
92 lesions)
Group 2  
(479 patients/ 
560 lesions) P
Extent of coronary disease, n (%)
Single vessel
Double vessel 
Triple vessel
LMCA
38 (48.1)
21 (26.6)
17 (21.5)
3 (3.8)
221 (46.1)
157 (32.8)
80 (16.7)
21 (4.4)
0.71
Treated vessel, n (%)
LAD  
LCx   
RCA   
39 (41.9)
8 (8.6)
34 (36.6)
211 (37.8)
52 (9.3)
181 (32.4)
0.28
Lesions with thrombus, n (%) 61 (65.6) 223 (34.4) < 0.001
Calcified lesions, n (%) 41 (44.1) 292 (52.2) 0.14
Type B2/C lesion, n (%) 80 (88.0) 434 (77.6) 0.09
Long lesions, n (%) 15 (16.1) 67 (12.0) 0.11
Bifurcations, n (%) 4 (4.2) 43 (7.7) 0.95
Pre-PCI coronary flow, n (%)
TIMI 0/1
TIMI 2/3
67 (72.8)
25 (27.2)
351 (62.7)
209 (37.3)
0.13
Collateral circulation, n (%) 27 (29.3) 156 (27.8) 0.84
RCA = right coronary artery; LCx = circumflex coronary artery; LAD = anterior descending artery; PCI = percutaneous coronary intervention; 
LMCA = left main coronary; TIMI = thrombolysis in myocardial infarction. 
Group 1 presented with a higher pre-PCI creatine 
kinase-MB fraction (127.7  ng/mL vs. 85.3  ng/mL; 
P = 0.01). Thrombotic lesions (65.6% vs. 34.4%; P < 0.001), 
the use of glycoprotein IIb/IIIa (48.1% vs. 30.7%; 
P = 0.001), and the use of direct stenting (54.4% vs. 
41.5%; P = 0.02) were also more frequent in this group. 
Larger diameter stents were also used (3.3 ± 0.6 mm 
vs. 3.1 ± 0.6 mm; P < 0.001). Transient coronary flow 
disturbances (no/slow-reflow) during PCI (16.8% vs. 
6.7%; P  <  0.001) were more frequent in group 1.
No differences were observed between the groups 
regarding the targeted vessel, extension and complex-
ity of the coronary disease, degree of the collateral 
circulation, pre-procedure coronary flow (TIMI), door-
to-balloon time (56.9 ± 110.1 minutes vs. 69.6 ± 138.3 
minutes; P = 0.6), or success of the procedure (93.7% 
vs. 92.3%; P  =  0.4). Despite a greater occurrence of 
transient coronary flow disturbances in group 1, these 
phenomena were successfully treated pharmacologi-
cally; therefore, the groups did not show differences in 
post-procedure TIMI flow (91.3% vs. 90.7% for groups 
1 and 2, respectively; P  =  0.576).
Hospital outcomes (Table 4) of the primary PCI 
showed no differences between the groups regarding 
the occurrence of MACCE, (6.3% vs. 6.5%; P  =  0.6), 
in-hospital mortality (5.1% vs. 3.8%; P = 0.58), stroke 
(1.3% vs. 0.4%; P = 0.09), or reinfarction (0 vs. 2.3%; 
P  =  0.17). No patient underwent emergency CABG 
surgery.
DISCUSSION
The presence of thrombus provides suboptimal 
results in PCI due to its potential displacement and 
fragmentation, leading to distal macro- and microem-
bolisation. Macroembolisation is defined as a failure 
of distal filling, with a sudden interruption in one of 
the branches of the peripheral coronary arteries of the 
vessel related to infarction, distal to the angioplasty 
site. Microembolisation results in microvascular dys-
function, which is evaluated through microbubble 
echocardiography in the risk area after primary PCI. 
These events have been associated with TIMI flow < 3 
and with reduced myocardial blush in spite of the 
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reopened artery (the no/slow-reflow phenomenon), slower 
ST-segment resolution rate, higher enzyme elevation, 
lower left ventricular ejection fraction and higher long-
term mortality rates.4–6,17
Thrombectomy, or mechanical removal of the thrombus 
from the coronary artery, can improve the prognosis after 
AMI, since, in theory, it can reduce the chances of distal 
embolisation of thrombus and its fatal consequences. 
TABLE 3 
Procedure-related Characteristics
Characteristics
Group 1
(79 patients/
92 lesions)
Group 2
(479 patients/
560 lesions) P
Door-to-balloon time, minutes 56.9 ± 110.1 69.6 ± 138.3 0.6
Pre-procedure CK-MB, ng/mL 127.7 ± 147.3 85.3 ± 134.6 0.01
Glycoprotein IIb/IIIa inhibitors, n (%) 38 (48.1) 147 (30.7) 0.001
Direct stenting technique, n (%) 50 (54.4) 232 (41.5) 0.02
Stent diameter, mm 3.3 ± 0.6 3.1 ± 0.6 < 0.001
Stent length, mm 20.6 ± 6.6 20.2 ± 6.6 0.65
Transitory no/slow-reflow 13 (16.8) 32 (6.7) < 0.001
Post-PCI coronary flow, n (%) 0.58
TIMI 0/1 0 10 (1.8)
TIMI 2 8 (8.7) 42 (7.5)
TIMI 3 84 (91.3) 508 (90.7)
Degree of stenosis, (%)
Pre 95.1 ± 12.6 93.0 ± 12.5 0.17
Post 10.1 ± 4.3 10.9 ± 7.5 0.58
Success of the procedure, n (%) 74 (93.7) 442 (92.3) 0.4
CK-MB = creatine kinase-MB fraction; PCI = percutaneous coronary intervention; TIMI = thrombolysis in myocardial infarction.
TABLE 4 
Clinical Outcomes During Hospital Stay
Characteristics
Group 1 
(n = 79)
Group 2 
(n = 479) P
MACCE, n (%) 5 (6.3) 31 (6.5) 0.6
All-cause mortality, n (%) 4 (5.1) 18 (3.8) 0.58
Stroke, n (%) 1 (1.3) 2 (0.4) 0.09
Reinfarction, n (%) 0 11 (2.3) 0.17
Emergency CABG, n(%) 0 0 NA
MACCE = major adverse cardiac and cerebrovascular events; n = number of patients; NA = non-applicable; CABG = coronary artery 
bypass graft surgery.
Thrombectomy leads to a better flow and immediate 
myocardial perfusion, as well as a reduction of infarc-
tion size and microvascular lesion (through enzymes and 
magnetic resonance), faster resolution of the ST-segment 
elevation, and higher myocardial blush, especially with the 
use of manual aspiration devices.18–20 Several randomised 
and controlled studies have demonstrated a reduction in 
death and reinfarction in patients with late follow-up at 
eight to 24 months after the AMI.9–11
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However, there is controversy regarding the use 
of aspiration devices, specifically whether they can be 
used universally or only for specific angiographic/clinical 
groups. The randomised study ‘Impact of thrombectomy 
with EXPort catheter in infarct-related artery during 
primary percutaneous coronary intervention (EXPIRA)’ 
considered as inclusion criteria the thrombus load (TIMI 
IIIA classification)21 ≥  3 and TIMI flow ≤  1, limiting 
their conclusions to this specific group of patients with 
AMI.10,18 The ‘Thrombus aspiration during percutaneous 
coronary intervention in acute myocardial infarction 
study (TAPAS),’ the most complete study to date, pre-
sented more consistent results regarding late mortality, 
and included patients with AMI without angiographic 
restrictions.11 The clinical and angiographic variables 
that best translate the benefits of thrombectomy still 
need to be defined.
In the present study, the use of aspiration devices was 
more prevalent in male patients and in tobacco smokers. 
The close relationship between tobacco smoking and 
coronary atherothrombosis may help explain this fact, 
as there is a higher occurrence of thrombotic coronary 
plaques among tobacco smokers.22 The greater increase in 
creatine kinase-MB fraction (CK-MB) before intervention 
demonstrates that thrombectomy was more frequently 
performed in more extensive infarctions.
As expected, among the angiographic features, the 
occurrence of thrombus-filled lesions was higher in pa-
tients in whom aspiration devices were used, regardless 
of the TIMI flow and the length of the coronary lesions. 
The thrombotic burden was not calculated, and the 
presence or angiographic suspicion of thrombus was 
only qualitatively considered. Greater use of glycopro-
tein IIb/IIIa inhibitors and of transient flow disturbances 
during the procedure (no/slow-reflow) suggest that the 
thrombus burden in these patients was more significant. 
A greater thrombus burden predicts the occurrence of 
adverse cardiovascular events after the primary PCI, 
either during acute phase or in the late phase, making 
it difficult to completely position the stent apposed to 
the vessel wall, which could predispose to thrombosis 
of the prosthesis.23,24
In the procedures performed with aspiration 
devices, a greater number of stents were implanted 
without pre-dilatation with balloon catheters (direct 
stenting technique). This finding may be explained by 
the restored flow after thrombectomy, which enables 
the identification of the characteristics and the presence 
of calcification, tortuosities, and obstruction length, as 
well as dimensions of the stent to be implanted without 
requiring pre-dilation. Such observations have been 
made in previous publications.25
As a favourable outcome with adjunct thrombectomy, 
observational studies have shown the stent implant to 
be shorter than the original thrombus-filled lesion.19 In 
the present study, there was a difference regarding stent 
diameter. The group in which aspiration devices were 
used received larger stents. The interaction between 
the thrombus and the production of vessel-constricting 
endothelial substances, which influence the calibre of 
the artery, may explain this finding.23
The success rates of the procedures in both groups 
studied were high, and the incidence of MACCE, rein-
farction, stroke, emergency CABG surgery, and death 
were low and similar between the groups.
Limitations of the study
Among the limitations of this study are the retro-
spective analysis of the data between two cohorts with 
non-adjustable clinical variables, the non-availability of 
parameters to evaluate post-aspiration myocardial perfu-
sion (myocardial blush and ST-segment resolution), the 
absence of late patient follow-up, and the fact that the 
procedures were performed in more than one centre. 
CONCLUSIONS
Thrombus aspiration catheters were used in ap-
proximately 15% of patients undergoing primary PCI, 
usually in AMIs with greater extension and thrombotic 
burden. Despite the more severe clinical-angiographic 
profile of this group, the success rate of the procedure 
was high and similar to that of low-risk patients.
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